Prof Anthony H Goldstone CBE – Clinical Director

  • Qualifications
    MA (Oxon), BM BCL, FRCP, FRCPE, FRCPath, CBE
  • Speciality
    Haematological oncology
  • Year qualified
    1968
  • Consulting address
    Harley Street at University College Hospital, 5th Floor, Macmillan Cancer Centre, Huntley Street, London WC1E 6AG
  • Research interests
    Dose-escalated therapy with stem cell rescue for the treatment of patients with leukaemia, lymphoma and myeloma as standard therapy.
  • Languages
    English, French
  • Biography

    Prof Anthony Goldstone CBE – Clinical Director, is one of the top haematologists in the world, carrying out research, trials and teaching in various aspects of haematology, especially leukaemia, lymphoma and myeloma. He has pioneered, with Prof Alan Burnett, the national randomised trials for acute leukaemia, studies that are at the forefront of the international contribution in AML and ALL. Through liaison with the Eastern Co-operative Oncology Group (ECOG) of the USA, he has also brought about the first major collaborative study in acute leukaemia between the UK’s Medical Research Council and a major United States collaborative group (UKALL 12/ECOG 2993). Prof Goldstone also established dose-escalated therapy with stem cell rescue as standard therapy for the treatment of patients with leukaemia, lymphoma and myeloma. He has given numerous lectures both nationally and internationally, and written 330 peer-reviewed publications in haematology. Prof Goldstone joined the University College Hospital as a haematology consultant in 1976 and set up the leukaemia and transplant service. He became the hospital’s first clinical director in 1988 and its first medical director in 1992, retaining this position until 2000, when he became the first director of services of the North London Cancer Network until 2009. He has been clinical director of Harley Street at University College Hospital since it formed in 2005 and was awarded a CBE for services to medicine in June 2008.